Bull case
The bull case requires both strong earnings delivery and the market pricing BTI more generously than it does today.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where BTI stock could go
The bull case requires both strong earnings delivery and the market pricing BTI more generously than it does today.
The base case reflects analyst consensus expectations — steady delivery without requiring a major catalyst or re-rating.
The bear case reflects a scenario where earnings shortfalls or multiple compression combine to materially reduce the stock from its current level.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

British American Tobacco is a global tobacco and nicotine company that manufactures and sells combustible cigarettes, vaping products, heated tobacco, and oral nicotine products. It generates revenue primarily from combustible cigarettes — which still contribute the majority of sales — alongside growing "new category" products like Vuse vaping devices and glo heated tobacco. The company's key advantage lies in its portfolio of iconic global brands — including Camel, Newport, and Lucky Strike — and its extensive international distribution network.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2024 | $2.55/$2.19 | +16.4% | $15.6B/$16.2B | -3.7% |
| Q1 2025 | $-0.40/$2.44 | -116.4% | $16.9B/$17.7B | -4.6% |
| Q3 2025 | $2.79/$2.24 | +24.6% | $16.4B/$16.2B | +1.3% |
| Q1 2026 | $2.55/$2.50 | +2.0% | $18.4B/$17.8B | +3.4% |
BTI beat EPS estimates in 3 of 4 tracked quarters. A strong delivery record supports forward estimate credibility.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $62 — implies +5.8% from today's price.
| Metric | BTI | S&P 500 | Consumer Defensive | 5Y Avg BTI |
|---|---|---|---|---|
| Forward PE | 16.5x | 18.8x-12% | 14.2x+16% | — |
| Trailing PE | 32.6x | 24.4x+33% | 18.9x+72% | 16.6x+96% |
| PEG Ratio | — | 1.66x | 1.92x | — |
| EV/EBITDA | 21.9x | 15.2x+44% | 11.1x+97% | 13.3x+64% |
| Price/FCF | 10.1x | 20.7x-51% | 15.3x-34% | 8.5x+19% |
| Price/Sales | 3.7x | 3.1x+20% | 0.9x+322% | 3.1x+21% |
| Dividend Yield | 5.29% | 1.91% | 3.06% | 6.20% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolBTI generates $18.7B in free cash flow at a 36.1% margin — returns 6.1% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~1.7 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
Investor concern around the company's 2026 outlook tracking toward the lower end of its medium-term growth targets.
Potential impact from the UK's plan to raise the tobacco purchasing age.
Recent stock price decline reflects negative investor sentiment.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
BTI's forward P/E of 11.40 suggests the stock may be undervalued relative to future earnings potential.
The company offers a range of tobacco and nicotine products including vapour, heated, and modern oral products, positioning it for evolving consumer preferences.
BTI operates across multiple regions including Americas, Europe, and Asia-Pacific, providing geographic diversification.
The stock's attractive valuation metrics and consistent performance suggest potential for compounding dividends.
Multiple investment analysts have published bullish theses on BTI, highlighting its investment merits.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
BTI BTI British American Tobacco p.l.c. | $127.8B | 16.5x | -0.3% | -20.8% | Buy | -32.1% |
MO MO Altria Group, Inc. | $115.6B | 12.2x | -1.6% | 36.9% | Buy | +3.9% |
PM PM Philip Morris International Inc. | $278.0B | 21.3x | +5.2% | 26.7% | Buy | +6.3% |
TPB TPB Turning Point Brands, Inc. | $1.6B | 57.4x | +6.3% | 11.5% | Buy | +56.5% |
UVV UVV Universal Corporation | $1.3B | 12.5x | +1.7% | 1.1% | Buy | — |
XXI XXII 22nd Century Group, Inc. | $2M | — | -19.8% | -44.9% | — | — |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
BTI returns 6.1% total yield, led by a 5.29% dividend. Buybacks add another 0.8%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $3.34 | — | — | — |
| 2025 | $3.17 | +6.4% | — | — |
| 2024 | $2.98 | +2.7% | 1.0% | 7.4% |
| 2023 | $2.90 | +10.0% | 0.2% | 7.9% |
| 2022 | $2.64 | -10.3% | 2.3% | 7.7% |
Common questions answered from live analyst data and company financials.
British American Tobacco p.l.c. (BTI) is rated Buy by Wall Street analysts as of 2026. Of 18 analysts covering the stock, 12 rate it Buy or Strong Buy, 4 rate it Hold, and 2 rate it Sell or Strong Sell. The consensus 12-month price target is $40, implying -32.1% from the current price of $59.
The Wall Street consensus price target for BTI is $40 based on 18 analyst estimates. The high-end target is $40 (-32.1% from today), and the low-end target is $40 (-32.1%).
BTI trades at 16.5x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals fair versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for BTI in 2026 are: (1) Growth outlook concerns — Investor concern around the company's 2026 outlook tracking toward the lower end of its medium-term growth targets. (2) Regulatory risk — Potential impact from the UK's plan to raise the tobacco purchasing age. (3) Market sentiment — Recent stock price decline reflects negative investor sentiment. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates BTI will report consensus revenue of $51.6B (-0.3% year-over-year) and EPS of $-2.67 (+45.2% year-over-year) for the upcoming fiscal year. The following year, analysts project $51.1B in revenue.
British American Tobacco p.l.c. is expected to report its next earnings on approximately 2026-07-30. Consensus expects EPS of $2.17 and revenue of $16.4B. Over recent quarters, BTI has beaten EPS estimates 58% of the time.
British American Tobacco p.l.c. (BTI) generated $18.7B in free cash flow over the trailing twelve months — a free cash flow margin of 36.1%. BTI returns capital to shareholders through dividends (5.3% yield) and share repurchases ($792M TTM).